Robert Radinsky
11Patents
4h-index
10Co-inventors
53Inventor score
Filing activity: Feb 23, 2006 → Jun 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8771695B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9101760B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 6 | Active |
| US7985559B2 | Methods of selecting epidermal growth factor receptor (EGFR) binding agents | Physics | 5 | Active |
| US7981605B2 | Epidermal growth factor receptor mutations | Physics | 5 | Active |
| US9803025B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 3 | Active |
| US9988462B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 2 | Active |
| US8546107B2 | Epidermal growth factor receptor mutations | Physics | 2 | Active |
| US12139549B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 0 | Active |
| US10030270B2 | K-ras mutations and anti-EGFr antibody therapy | Chemistry; Metallurgy | 0 | Active |
| US11155876B2 | K-ras mutations and anti-EGFr antibody therapy | Chemistry; Metallurgy | 0 | Active |
| US9097729B2 | Methods of selecting epidermal growth factor receptor (EGFr) binding agents | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.